COMPARISON OF HIGH-DOSE EBRT AND EBRT WITH BRACHYTHERAPY BOOST IN TREATMENT OF PROSTATE CANCER PATIENTS

被引:0
|
作者
Smolska-Ciszewska, B. [1 ]
Miszczyk, L. [2 ]
Bialas, B. [3 ]
Gawkowska-Suwinska, M. [1 ]
Plewicki, G. [1 ]
Fijalkowski, M. [3 ]
Giglok, M. [1 ]
Behrendt, K. [1 ]
Nowicka, E. [1 ]
Zajusz, A. [1 ]
机构
[1] Marie Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Radiotherapy Clin 2, Gliwice, Poland
[2] Marie Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Radiotherapy, Gliwice, Poland
[3] Marie Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Brachytherapy, Gliwice, Poland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1181
引用
收藏
页码:S398 / S398
页数:1
相关论文
共 50 条
  • [11] Hypofractionated EBRT and single fraction HDR brachytherapy for patients with prostate cancer
    Kazberuk, D. E.
    Filipowski, T. M.
    Szmigiel-Trzcinska, A.
    Niksa, M.
    Hempel, D.
    Topczewska-Bruns, J.
    Nowik, W.
    Pancewicz-Janczuk, B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S973 - S973
  • [12] Supplemental EBRT and/or ADT after brachytherapy for prostate cancer
    [J]. Nature Clinical Practice Urology, 2005, 2 (2): : 63 - 63
  • [13] External beam radiotherapy (EBRT) and high dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: Whole pelvis or prostate-only EBRT?
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Hoskin, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [14] Brachytherapy versus EBRT boost for cervical cancer: is the standard better?
    Delgado, D.
    Figueiredo, A.
    Leitao Santos, J.
    Florindo, A.
    Mendonca, V.
    Lemos, M.
    Abdulrehman, M.
    De Pina, M. F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S813 - S814
  • [15] Brachytherapy plus EBRT reduces the risk of ECE in prostate cancer patients
    [J]. Nature Clinical Practice Urology, 2007, 4 (6): : 295 - 295
  • [16] Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone
    Fang, Fu-Min
    Wang, Yu-Ming
    Wang, Chong-Jong
    Huang, Hsuan-Ying
    Chiang, Po-Hui
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (07) : 474 - 479
  • [17] External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Alonzi, Roberto
    Wylie, James
    Ahmed, Imtiaz
    Henry, Ann
    Heath, Catherine
    Hoskin, Peter J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (03): : 525 - 533
  • [18] Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
    Moll, Matthias
    Magrowski, Lukasz
    Mittlboeck, Martina
    Heinzl, Harald
    Kirisits, Christian
    Ciepal, Jakub
    Masri, Oliwia
    Heilemann, Gerd
    Stando, Rafal
    Krzysztofiak, Tomasz
    Depowska, Gabriela
    d'Amico, Andrea
    Techmanski, Tomasz
    Kozub, Anna
    Majewski, Wojciech
    Suwinski, Rafal
    Wojcieszek, Piotr
    Sadowski, Jacek
    Widder, Joachim
    Goldner, Gregor
    Miszczyk, Marcin
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2024,
  • [19] Does Phoenix Failure Definition Apply to EBRT plus HDR Brachytherapy Boost in Prostate Cancer?
    Martin, A. G.
    Vigneault, E.
    Foster, W.
    Aubin, S.
    Beaulieu, L.
    Despres, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S415 - S416
  • [20] Comparing the Cost Effectiveness of Hypofractionated EBRT with High Dose Rate Brachytherapy Boost and Intensity Modulated Radiation Therapy for the Treatment of Intermediate/High-Risk Prostate Cancer
    Lanni, T. B.
    Ghilezan, M. I.
    Gustafson, G. S.
    Marvin, K. S.
    Ye, H.
    Martinez, A. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S359 - S359